Анемии в пожилом и старческом возрасте

Анемии в пожилом и старческом возрасте

Автор: Богданов А. Н., Волошин С. В.

Журнал: Вестник гематологии @bulletin-of-hematology

Рубрика: Обзор литературы

Статья в выпуске: 1 т.17, 2021 года.

Бесплатный доступ

Анемический синдром выявляется у 1/3 популяции. Гериатрические пациенты являются одной из основных групп риска развития анемии. Наиболее распространенными видами анемий у пациентов старших возрастных групп являются железодефицитные и В12дефицитные анемии, анемии хронических заболеваний, анемии при патологии почек и миелодиспластическом синдроме. Любая анемия приводит к снижению качества жизни, повышению заболеваемости и летальности и требует своевременной диагностики и лечения.

Анемии, частота в популяции, гериатрические пациенты, основные виды анемии, диагностика, лечение

Короткий адрес: https://sciup.org/170175044

IDR: 170175044

Список литературы Анемии в пожилом и старческом возрасте

  • Kassebaum N. J., Jasrasaria R., Naghavi M. et al. A systematic analysis of global anemia burden from 1990 to 2010 // Blood — 2014 — Vol. 123. — P. 615–624.
  • Chaparro C. M., Suchdev P. S. Anemia epidemiology, pathophysiology, and etiology in low- and middleincome countries // Ann. N Y Acad. Sci. — 2019 — Vol. 1450, N1. — P. 15–31.
  • Гериатрическая гематология. Заболевания системы крови в старших возрастных группах / Под ред. Л. Д. Гриншпун, А. В. Пивника. М.: Медиум, 2012, Т. 2. С. 407–452.
  • Stauder R, Valent P., Theurl I. Anemia at older age: etiologies, clinical implications, and management // Blood. — 2018 — Vol.131, N5. — P. 505–514.
  • Lanier J. B., Park J. J., Callahan R. C. Anemia in older adults // Am Fam Physician– 2018 –Vol. 98, N7. — P. 437–442.
  • Merchant A. A., Roy C. N. Not so benign haematology: anaemia of the elderly // Br. J. Haematol. — 2012– Vol. 156. № 2. — P. 173–185.
  • Ageing and health. WHO. 2018. http://www. who. int/mediacentre/factsheets/fs404/en/.
  • Blanc B., Finch C. A., Hallberg L. et al. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968–Vol. 405. —P. 5–37.
  • Patel K. V., Longo D. L., Guralnik J. M. Hemoglobin concentration and the risk of death in older adults: differences by race/ethnicity in the NHANES III Follow-up // Brit. J. Haematol. — 2009. —Vol. 145. № 4. —P. 514–523.
  • Zakai N. A., Katz R., Hirsch C., et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study // Arch. Intern. Med. — 2005 –Vol.165, N19. — P. 2214–2220.
  • Culleton B. F., Manns B. J., Zhang J., et al. Impact of anemia on hospitalization and mortality in older adults / Blood — 2006. — Vol. 107, N10– P. 3841–3846.
  • Beutler E., Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? // Blood– 2006 — Vol. 107, N5. — P. 1747–1750.
  • Stauder R., Thein S. L. Anemia in the elderly: clinical implications and new therapeutic concepts // Haematologica — 2014 — Vol. 99, N7. — P. 1127–1130.
  • Gaskell H, Derry S, Andrew Moore R et al. Prevalence of anaemia in older persons: systematic review // BMC Geriatr. — 2008 — Vol. 8:1https://doi. org/10.1186/1471–2318–8–1.
  • denElzen W. P. J., Gussekloo J. Anaemia in older person // Netherlands J. Med. — 2011. — Vol. 69. № 6. — P. 260–267.
  • Bach V., Schruckmayer G., Sam I. et al. Prevalence and possible causes of anemia in the elderly: a crosssectional analysis of a large European university hospital cohort // Clin. Interv. Aging — 2014, — Vol. 9. — P. 1187–1196.
  • Beerman I., Bhattacharya D., Zandi S. et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion // Proc. Nat. Acad. Sci. USA. — 2010. — Vol. 107. — P. 5465–5470.
  • den Elzen W. P. J., Martin-Ruiz C., von Zglinicki T. Telomere length and anaemia in old age: results from the Newcastle 85-plus Study and the Leiden 85-plus Study // Age Ageing. —2011. —Vol. 40. № 4. —P. 494–500.
  • Burgstaller S., Wiesinger P., Stauder R. Myelodysplastic syndromes in the elderly: treatment options and personalized management // Drugs Aging. —2015 — Vol. 32. P. 891–905.
  • Lippi G., Franchini M., Guidi G. C. Determinants of anaemia in the very elderly: a major contribution from impaired renal function? // Blood Transf. — 2010. — Vol. 8. — P. 44–48.
  • Adamson J. W. Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation // Adv. ChronicKidneyDis. —2009. — Vol. 16. — P. 76–82.
  • Ershler W. B., Sheng S., McKelvey J. et al. Serum erythropoietin and aging: a longitudinal analysis // J. Amer. Geriatr. Soc. —2005. —Vol. 53. — P. 1360–1365.
  • Ausk K. J., Ioannou G. N. Is obesity associated with anemia of chronic disease? A population-based study // Obesity (Silver Spring). — 2008. —Vol. 16. —P. 2356–2361.
  • Bayne S., Jones M. E., Li H., Liu J. P. Potential roles for estrogen in regulation of telomerase activity in aging // Ann. NY Acad. Scienc. — 2007. —Vol. 114. —P. 48–55.
  • Ferrucci L., Maggio M., Longo D. L. Low testosterone levels and the risk of anemia in older men and women // Arch. Int. Med. —2006. — Vol. 166. № 13. — P. 1380–1388.
  • Artz AS, Thirman MJ. Unexplained anemia predominates despite an intensive evaluation in a racially diverse cohort of older adults from a referral anemia clinic // J. Gerontol. ABiol. Sci. Med. Sci. — 2011. — Vol. 66A, N8. — P. 925–932.
  • Bross M. N., Soch K., Smith-Knuppel T. Anemia in older persons // Amer. Fam. Physician. —2010. — Vol. 82, № 5. — P. 480–487.
  • Valent P., Orazi A., Steensma D. P. et al. Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions // Oncotarget — 2017– Vol. 8. — N43. — P. 73483–73500.
  • Bach V., Schruckmayer G., Sam I. et al. Prevalence and possible causes of anemia in the elderly: a crosssectional analysis of a large European university hospital cohort // Clin. Interv. Aging. — 2014. — Vol. 9. — P. 1187–1196.
  • Zakai N. A., French B., Arnold A. M., et al. Hemoglobin decline, function, and mortality in the elderly: the cardiovascular health study // Am. J. Hematol. — 2013. — Vol. 88, N1. — P. 5–9.
  • Joosten E., Detroyer E., Milisen K. Effect of anaemia on hand grip strength, walking speed, functionality and 1 year mortality in older hospitalized patients // BMC Geriatr. — 2016. — Vol. 16, N1. P. 153. https://doi.org/10.1186/s12877–016–0326-y.
  • Goodnough L. T, Schrier SL. Evaluation and management of anemia in the elderly // Am J Hematol. — 2014. — Vol. 89, N1. — P. 88–96.
  • Nairz M., Theurl I., Wolf D., Weiss G. Differential diagnosis and mechanisms of anemia of inflammation // Wien Med. Wochenschr. — 2016 — Vol.166. N13 — P. 411–423.
  • Fairweather-TaitS. J., Wawer A. A., Gillings R. et al. Iron status in the elderly // Mech Ageing Dev. — 2014 — Vol. 136–137, N100. — P. 22–28.
  • Wawer A. A., Jennings A., Fairwetter-Tait S. J. Iron status in the elderly: a review of recent evidence // Mechanism of Ageing and Development — 2018 — Vol.185 –P. 55–73.
  • Busti F, Campostrini N., Martinelli N., Girelli D. Iron deficiency in the elderly population, revisited in the hepcidin era // Front Pharmacol. — 2014 — Vol. 5 — P. 83. doi: 10.3389/fphar.2014.00083.
  • Krayenbuehl P. A., Battegay E., Breymann C. et al. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration // Blood — 2011 — Vol. 118 — P. 3222– 3227.
  • Hsu H. S., Li C. I., Liu C. S. et al. Iron deficiency is associated with increased risk for cardiovascular disease and all-cause mortality in the elderly living in long-term care facilities. // Nutrition –2013– Vol. 29, N5. —P.737–43.
  • Morkedal B., Laugsand L. E., Romundstad P. R., Vatten L. J. Mortality from ischaemic heart disease: sexspecific effects of transferrin saturation, serum iron, and total iron binding capacity. The HUNT study // Eur. J. Cardiovasc. Prev. Rehabil. — 2011 — Vol.18 — P. 687–694.
  • Camaschella C., Nai A., Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era // Haematologica. — 2020. — Vol. 105://doi. org/10.3324/haematol.2019.232124
  • Yiannikourides A., Latunde-Dada G. O. A short review of iron metabolism and pathophysiology of iron disorders // Medicines (Basel). — 2019 — Vol. 6, N3 — Р. 85. doi: 10.3390/medicines6030085
  • Lopez A., Cacoub P., Macdaugall I. C., Peyrin-Biroulet L. Iron deficiency anaemia // Lancet– 2016 –Vol. 387 — P. 907–916.
  • Suchdev P. S., Williams A. M., Mei Z. et al. Assessment of iron status in settings of inflammation: challenges and potential approaches // Am. J. Clin. Nutr. — 2017 — Vol. 106. — P. 1626–1633.
  • Cappellini M. D., Comin-Colet J., de Francisco A. et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management // Am. J. Hematol. — 2017– Vol. 92– P. 1068–1078.
  • Infusino I., Braga F., Dolci A., Panteghini M. Soluble transferrin receptor (sTfR) and sTfR/log ferritin index for the diagnosis of iron-deficiency anemia. A meta-analysis // Am J ClinPathol –2012– Vol. 138– P. 642–649.
  • Buttarello M. Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how? // International Journal of laboratory hematology. —2016 — Vol.38 — Issue S1https://doi. org/10.1111/ijlh.12500.
  • Karlsson T. Mass spectrometry evaluation of the hepcidin — 25 assay in the differential diagnosis of irondeficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients // Eur. J. Haematol — 2015– Vol. 5 — P. 467–471.
  • Barron B. A., Hoyer J. D., Tefferi A. A bone marrow report of absent stainable iron is not diagnostic of irondeficiency // Ann. Hematol. — 2001. — Vol. 80–P. 166–169.
  • Lopez-Contreas M. J., Zamoro-Portero S, Lopez MA et al. Dietary and iron status of instutionalized elderly people: relationship with different factors // J. Nutr. Health Aging –2010 –Vol.10 — P. 816–821.
  • Annibale B., Capuro G., Chistolini A. et al. Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms // Am. J. Med. — 2001 — Vol. 111– P. 439–445.
  • Goddard A. F, James M. W., McIntyre A. S., Scott B. B. Guidelines for the management of iron deficiency anemia // Gut– 2011 –Vol. 60. —P. 1309–1316.
  • Soon A., Cohen B. L., Groessl E. J., Ho S. B. Long-term outcomes and prognostic factors for patients with endoscopy-negative iron deficiency // Dig. Dis. Sci. —2013– Vol. 58 — P. 488–495.
  • Muhammad A., Vidyarthi G., Brady P. Role of small bowel capsule endoscopy in the diagnosis and management of iron deficiency anemia in the elderly: a comprehensive review of the current literature // World J. Gastroenterol . —2014. — Vol. 20 — P. 8416–8423.
  • Hershko C, Camaschella C. How I treat unexplained refractory iron-deficiency anemia // Blood –2014 — Vol. 123 — P. 326–333.
  • Pasricha S-R., Drakesmith H., Black J. et al. Control of iron deficiency anemia in low- and middle-income countries // Blood –2013 — Vol.121, N14 — P. 2607–2617.
  • Румянцев А. Г., Масчан А. А., Чернов В. М., Тарасова И. С. Федеральные клинические рекомендации по диагностике и лечению железодефицитной анемии. М.: 2015. 16 с.
  • Moretti D., Goede J. S., Zeder C. et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice daily dosis in iron-depleted young women // Blood. — 2015. —Vol. 126. — P. 1981– 1989.
  • Auerbach M., Adamson J. W. How we diagnose and treat iron deficiency anaemia // Am. J. Hematol. — 2016 — Vol. 91. — P. 31–38.
  • Beyer I., Compte N., Busuioc A. et al. Anemia and transfusions in geriatric patients: a time for evaluation // Hematology. — 2010 — Vol. 15, N2. — P. 116–121.
  • ABIM Foundation. Choosing Wisely: lists — American Society of Hematology. http://www. choosingwisely. org/clinician-lists/american-society-hematology-red-blood-cell-transfusions-for-anemia / Accessed 22 September 2017
  • Weiss G., Ganz T., Goodnough L. T. Anemia of inflammation // Blood-2019– Vol. 133, N1. — P. 40–50.
  • Madu A. J., Ughasoro M. D. Anaemia of chronic disease: an in-depth review // Med. Princ. Pract. —2017. — Vol. 26, N1. — P. 1–9.
  • Рукавицын О. А. Анемия хронических заболеваний: отдельные аспекты патогенеза и пути коррекции // Онкогематология — 2016. — Т 11, № 1. — С. 37–46.
  • Muckenthaler M. U., Rivella S., Hentze M. W., Galy B. A red carpet for iron metabolism. Cell // 2017. — Vol.168, N3. — P. 344–361.
  • Latour C., Wlodarczyk M. F., Jung G., et al. Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia // Haematologica — 2017. — Vol. 102, N1. — P. 60–68.
  • Dallalio G., Means R. T. Jr. Effects of oxidative stress on human erythroid colony formation: modulation by gamma-interferon // J. Lab. Clin. Med. —2003. — Vol. 141, N6. — P. 395–400.
  • Libregts S. F., Gutierrez L., de Bruin A. M., et al. Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis // Blood. — 2011. — Vol.118, N9. — P. 2578–2588.
  • Gaspar B. L., Sharma P., Das R. Anemia in malignancies: pathogenetic and diagnostic considerations // Hematology. — 2015. — Vol. 20. — P. 18–25.
  • Camaschella C. Iron-deficiency anemia // N Engl J Med. — 2015. — Vol. 372. — P. 1832–1843.
  • Spivak J. L. Iron and the anemia of chronic disease // Oncology (Williston Park) — 2002. — Vol. 16. — P. 25–33.
  • Богданов А. Н., Волошин С. В., Кулибаба Т. Г. и др. Изменения системы крови в клинической практике. СПб: Фолиант, 2017: 172 с.
  • Joosten E. Iron deficiency anemia in older adults: a review // Geriatr. Gerontol. Int. — 2018. — Vol. 18. — P. 373–379.
  • Petzer V., Theurl I., Weiss G. Established and emerging concepts to treat imbalances of iron homeostasis in inflammatory diseases // Pharmaceuticals (Basel). —2018. Vol. 11. — P. 135.
  • Przybyszewska J., Zekanowska E., Kedziora-Kornatowska K., et al. Serum prohepcidin and other iron metabolism parameters in elderly patients with anemia of chronic disease and with iron deficiency anemia // Pol. Arch. Med. Wewn. —2013. — Vol. 123. — P. 105–111.
  • Cappellini M. D., Comin-Colet J., de Francisco A. et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management // Am. J. Hematol. —2017– Vol.92– P. 1068–1078.
  • Румянцев А. Г., Масчан А. А. Федеральные клинические рекомендации по диагностике и лечению анемий хронических болезней. М., 2014. —9 с.
  • Шило В. Ю., Добронравов В. А., Земченков А. Ю. и др. Национальные рекомендации «Диагностика и лечение анемии при хронической болезни почек». М., 2014. — 35 с.
  • Docherty A. B., Turgeon A. F., Walsh T. S. Best practice in critical care: anaemia in acute and critical illness // Transfus. Med. — 2018. — Vol. 28, N2. — P. 181–189.
  • Casper C., Chaturvedi S., Munshi N. et al. Analysis of inflammatory and anemia-related biomarkers in a randomized, double-blind, placebo-controlled study of siltuximab (anti-IL6 monoclonal antibody) in patients with multicentricCastleman disease // Clin. Cancer Res. — 2015. — Vol. 21. — P. 4294–4304.
  • Katsarou A., Pantopoulos K. Hepcidin therapeutics // Pharmaceuticals (Basel). —2018. —Vol. 11, N4. — P. 127.
  • Nagao T., Hirokawa M. Diagnosis and treatment of macrocytic anemias in adults // J Gen Fam Med. — 2017. — Vol. 18, N5. — P. 200–204.
  • Socha D. S., DeSouza S. I., Flagg A. et al. Severe megaloblastic anemia: Vitamin deficiency and other causes // Cleveland Clinic Journal of Medicine– 2020 — Vol. 87, N3. — P. 153–164.
  • Aslinia F., Mazza J. J., Yale S. H. Megaloblastic anemia and other causes of macrocytosis // Clin. Med. Res. — 2006. — Vol. № 3. — P. 236–241.
  • Steensma D. P. Dysplasia has a differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors // Curr. Hematol. Malig. Rep. — 2012. — Vol. 7, N4. — P. 310–320.
  • Savage D. G, Ogundipe A, Allen R. H. et al. Etiology and diagnostic evaluation of macrocytosis // Am. J. Med. Sci. — 2000. — Vol. 319. — P. 343–352.
  • Seppa K, Heinila K, Sillanaukee P, Saarni M. Evaluation of macrocytosis by general practitioners // J Stud Alcohol. —1996. — Vol. 57. — P. 97–100.
  • Mahmoud MY, Lugon M, Anderson CC. Unexplained macrocytosis in elderly patient // Age Ageing. —1996. —Vol. 25. — P. 310–312.
  • Green R., Datta Mitra A. Megaloblasticanemias: nutritional and other causes // Med. Clin. North Am. —2017. — Vol. 101, N2. — P. 297–317.
  • Wong C. W. Vitamin B12 deficiency in the elderly: is it worth screening? // Нong Kong Med. J. 2015. — Vol. 21, N2. — P. 155–164.
  • Rojas Hernandez C. M., OO TH Advances in mechanisms, diagnosis, and treatment of pernicious anemia // Discov. Med. — 2015 — Vol. 104. — P. 159–168.
  • Alpers D. H., Russell-Jones G. Gastric intrinsic factor: the gastric and small intestinal stages of cobalamin absorption. A personal journey // Biochimi. — 2013 — Vol. 95, N5. — P. 989–994.
  • Лукина Е. А. Цветаева Н. В., Двирнык В. Н. и др. В12-дефицитная анемия. Клинические рекомендации. М., 2020. — 28 с.
  • Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis–pathogenesis, pathology and management // Nat Rev GastroenterolHepatol. — 2013. — Vol. 10. — P. 529–541.
  • Andres E., Goichot B., Schlienger J. L. Food-cobalamin malabsorption: a usual cause of vitamin B12 deficiency // Arch Intern Med. —2000. — Vol. 160. — P. 2061–2062
  • Stover P. J. Vitamin B12 and older adults // Curr. Opin. Clin. Nutr. Metab. Care. — 2010. — Vol. 13. — P. 24– 27.
  • denElzen W. P. J., van der Weele G. M., Gussekloo J. et al. Subnormal vitamin B12 concentrations and anaemia in older people: a systematic review//BMC Geriatr. —2010. —Vol. 10. —P. 42.
  • Oo T. H. Diagnostic difficulties in Pernicious Anemia // Discov. Med. — 2019. — Vol. 28. — P. 247–253.
  • Toh B-H. Pathophysiology and laboratory diagnosis of pernicious anemia // Immunol. Res. —2017. — Vol. 65. — P. 326–30.
  • Stabler S. P. Clinical practice. Vitamin B12 deficiency // N. Engl. J. Med. — 2013. — Vol. 368, N2. — P. 149– 160.
  • Воробьев А. И. Руководство по гематологии, «Ньюдиамед», М, 2005, т. 3, с. 198–210.
  • Лукина Е. А. Цветаева Н. В., Сысоева Е. П. и др. Фолиеводефицитная анемия. Клинические рекомендации. М., 2020. — 27 с.
  • Kaferle J, Strzoda CE. Evaluation of macrocytosis // Am Fam Physician. — 2009. — Vol.79. — P. 203–208.
  • Shargian-Alon L., Pazgal I., Raanani P., Rachmilewitz E. Thalassemia major and intermedia in older patients — a single center experience // Blood. — 2014. — Vol.124, N21. — P. 2685. https://doi. org/10.1182/blood. V124.21.2685.2685
  • Thein S. L., How I treat the older adult with sickle cell disease // Blood. — 2018 — Vol. 132, N17. — P. 1750–1760.
  • Hoffman PC. Immune hemolytic anemia — selected topics // Hematology Am. Soc. Hematol. Educ. Program. — 2009. — N. 1. — P. 80–86.
  • Roth S., Obrecht V., Putetto M. et al. Anemia in the elderly: experience in an acute geriatric unit and recommendations // Rev Med Intern. — 2009. — Vol.30. — S111.
  • Zulfiqar A-A., Pennaforte J-L., Andres E. Autoimmune hemolytic anemia in individuals aged 75 and older: a study of 10 individuals // J AmerGer Soc. — 2016. — Vol. 64, N6. — P. 1372–1374.
  • Zeerleder S. Autoimmune haemolyticanaemia — a practical guide to cope with diagnostic and theurapeutic challenge // Netherlands J. Med. — 2011. — Vol. 69. — P. 177–184.
  • Jager U., Barcellini W., Broome C. M. et alDiagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting // Blood Reviews. — 2020. — Vol.41. — P. 100648. https://doi. org/10.1016/j. blre.2019.
  • Contejean A., Resche-Rigon M., JeromeTamburini J. et al. Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia // Haematologica. — 2019 — Vol. 104, N2. — P. 256–262.
  • Young N. S., Kaufman D. W. The epidemiology of acquired aplastic anemia // Haematologica. — 2008. — P. 93, N4. — P. 489–492.
  • Montane E., Ibanez L., Vidal X., et al. Epidemiology of aplastic anemia: a prospective multicenter study // Haematologica. — 2008. — Vol. 93, N4. — P. 518–523.
  • Tichelli A., Rovo A., Marsh J. C. W. Congenital and Acquired Bone Marrow Failure. Chapter 12 — Treatment of Elderly Patients With Aplastic Anemia. — 2017. — P. 141–151.
  • Price E. A., Mehra R., Holmes T. H., Schrier S. L. Anemia in older persons: etiology and evaluation // Blood Cells Molec. Dis. —2011. —Vol. 46. —P. 159–165.
Еще
Статья научная
SciUp 2024 © 2024 ©